Q2 2026 Holdings
Filed 2026-08-14 | 12 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $175.5M | 6,412,780 | 16.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $155.8M | 4,540,132 | 14.2% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $155.4M | 3,728,738 | 14.1% |
| Seaport Therapeutics Inc(SPTX) | COMMON STOCK | 81221K108 | $136.6M | 6,294,951 | 12.4% |
| Erasca Inc(ERAS) | COM | 29479A108 | $129.9M | 7,091,557 | 11.8% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $129.4M | 12,694,163 | 11.8% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $123.0M | 4,120,053 | 11.2% |
| Lyell Immunopharma Inc(LYEL) | COM NEW | 55083R203 | $45.5M | 3,247,162 | 4.1% |
| Generate Biomedicines Inc(GENB) | COM SHS | 370920100 | $32.8M | 1,944,426 | 3.0% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $8.4M | 217,834 | 0.8% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $6.7M | 2,694,095 | 0.6% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.3M | 8,055,916 | 0.1% |